NBC Securities
LGND icon

NBC Securities’s Ligand Pharmaceuticals LGND Stock Holding History

NBC Securities’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$87.5K Hold
280
– – 0.01% 1124
2026
Q2 		$88.5K Buy
+280
New +$66K 0.01% 1116

Other funds holding LGND

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

NBC Securities's LGND Position: Q3 2026 in Review

NBC Securities held its Ligand Pharmaceuticals (LGND) position steady in Q3 2026 at 280 shares worth $87.5K. The position accounts for 0.01% of the portfolio, ranked #1124.

NBC Securities first reported a position in LGND in Q2 2026 and has held it in 2 quarters since. The position peaked at $88.5K in Q2 2026. 348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • NBC Securities held 280 shares of Ligand Pharmaceuticals worth $87.5K as of Q3 2026.
  • NBC Securities left its Ligand Pharmaceuticals share count unchanged in Q3 2026.
  • Ligand Pharmaceuticals made up 0.01% of NBC Securities's portfolio in Q3 2026, its #1124 holding.
  • NBC Securities first reported a position in Ligand Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • NBC Securities's Ligand Pharmaceuticals position peaked at $88.5K in Q2 2026.
  • 348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on NBC Securities's 13F filing for Q3 2026, filed 26 Oct 2026.